Metabolic Fatty Liver Disease in Children: A Growing Public Health Problem
Metabolic-associated fatty liver disease (MAFLD), previously called nonalcoholic fatty liver diseases (NAFLD), is one of the most important causes of chronic liver disease worldwide and will likely become the leading cause of end-stage liver disease in the decades ahead. MAFLD covers a continuum of...
Main Authors: | Sébastien Le Garf, Véronique Nègre, Rodolphe Anty, Philippe Gual |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/12/1915 |
Similar Items
-
Healthy dietary patterns and metabolic dysfunction-associated fatty liver disease in less-developed ethnic minority regions: a large cross-sectional study
by: Xiaofen Xie, et al.
Published: (2022-01-01) -
Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease
by: Kevan Josloff, et al.
Published: (2022-11-01) -
COVID-19 and Fatty Liver Disorders
by: Maria Guarino, et al.
Published: (2023-06-01) -
From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?
by: Marta Flisiak-Jackiewicz, et al.
Published: (2021-03-01) -
MAFLD: How is it different from NAFLD?
by: Cameron Gofton, et al.
Published: (2023-02-01)